View in EDS

Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis.

Saved in:
Bibliographic Details
Title: Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis.
Authors: Vogiatzi F; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Heymann J; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Müller K; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Winterberg D; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Drakul A; Division of Pediatric Oncology, and Children Research Center, University Childreńs Hospital, Zurich, Switzerland., Rösner T; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Lenk L; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Heib M; Institute of Immunology, Christian-Albrechts-University Kiel, Kiel, Germany., Gehlert CL; Department of Medicine II, Division of Antibody-Based Immunotherapy, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Cario G; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Schrappe M; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Claviez A; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Bornhauser B; Division of Pediatric Oncology, and Children Research Center, University Childreńs Hospital, Zurich, Switzerland., Bourquin JP; Division of Pediatric Oncology, and Children Research Center, University Childreńs Hospital, Zurich, Switzerland., Bomken S; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Adam D; Institute of Immunology, Christian-Albrechts-University Kiel, Kiel, Germany., Frielitz FS; Institute of Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany., Maecker-Kolhoff B; Department of Pediatrics, Hannover Medical School, Hannover, Germany., Stanulla M; Department of Pediatrics, Hannover Medical School, Hannover, Germany., Valerius T; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Peipp M; Department of Medicine II, Division of Antibody-Based Immunotherapy, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Kellner C; Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Munich, Germany; and., Schewe DM; Department of Pediatrics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Source: Blood advances [Blood Adv] 2022 Aug 23; Vol. 6 (16), pp. 4847-4858.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35820018
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vogiatzi+F%22">Vogiatzi F</searchLink>; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Heymann+J%22">Heymann J</searchLink>; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+K%22">Müller K</searchLink>; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Winterberg+D%22">Winterberg D</searchLink>; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Drakul+A%22">Drakul A</searchLink>; Division of Pediatric Oncology, and Children Research Center, University Childreńs Hospital, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rösner+T%22">Rösner T</searchLink>; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Lenk+L%22">Lenk L</searchLink>; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Heib+M%22">Heib M</searchLink>; Institute of Immunology, Christian-Albrechts-University Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Gehlert+CL%22">Gehlert CL</searchLink>; Department of Medicine II, Division of Antibody-Based Immunotherapy, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Cario+G%22">Cario G</searchLink>; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Schrappe+M%22">Schrappe M</searchLink>; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Claviez+A%22">Claviez A</searchLink>; Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Bornhauser+B%22">Bornhauser B</searchLink>; Division of Pediatric Oncology, and Children Research Center, University Childreńs Hospital, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bourquin+JP%22">Bourquin JP</searchLink>; Division of Pediatric Oncology, and Children Research Center, University Childreńs Hospital, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bomken+S%22">Bomken S</searchLink>; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Adam+D%22">Adam D</searchLink>; Institute of Immunology, Christian-Albrechts-University Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Frielitz+FS%22">Frielitz FS</searchLink>; Institute of Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Maecker-Kolhoff+B%22">Maecker-Kolhoff B</searchLink>; Department of Pediatrics, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Stanulla+M%22">Stanulla M</searchLink>; Department of Pediatrics, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Valerius+T%22">Valerius T</searchLink>; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Peipp+M%22">Peipp M</searchLink>; Department of Medicine II, Division of Antibody-Based Immunotherapy, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Kellner+C%22">Kellner C</searchLink>; Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Munich, Germany; and.<br /><searchLink fieldCode="AU" term="%22Schewe+DM%22">Schewe DM</searchLink>; Department of Pediatrics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2022 Aug 23; Vol. 6 (16), pp. 4847-4858.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35820018
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2022007364
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4847
    Titles:
      – TitleFull: Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vogiatzi F
      – PersonEntity:
          Name:
            NameFull: Heymann J
      – PersonEntity:
          Name:
            NameFull: Müller K
      – PersonEntity:
          Name:
            NameFull: Winterberg D
      – PersonEntity:
          Name:
            NameFull: Drakul A
      – PersonEntity:
          Name:
            NameFull: Rösner T
      – PersonEntity:
          Name:
            NameFull: Lenk L
      – PersonEntity:
          Name:
            NameFull: Heib M
      – PersonEntity:
          Name:
            NameFull: Gehlert CL
      – PersonEntity:
          Name:
            NameFull: Cario G
      – PersonEntity:
          Name:
            NameFull: Schrappe M
      – PersonEntity:
          Name:
            NameFull: Claviez A
      – PersonEntity:
          Name:
            NameFull: Bornhauser B
      – PersonEntity:
          Name:
            NameFull: Bourquin JP
      – PersonEntity:
          Name:
            NameFull: Bomken S
      – PersonEntity:
          Name:
            NameFull: Adam D
      – PersonEntity:
          Name:
            NameFull: Frielitz FS
      – PersonEntity:
          Name:
            NameFull: Maecker-Kolhoff B
      – PersonEntity:
          Name:
            NameFull: Stanulla M
      – PersonEntity:
          Name:
            NameFull: Valerius T
      – PersonEntity:
          Name:
            NameFull: Peipp M
      – PersonEntity:
          Name:
            NameFull: Kellner C
      – PersonEntity:
          Name:
            NameFull: Schewe DM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 08
              Text: 2022 Aug 23
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1